Nemaura Medical Inc. (NMRD)
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
$1.14M
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
32.00
New York, NY
Nov 04, 2014
-0.07
$-0.39
0.19
0.35
766.22%
-0.64
0.04
-0.50
-4.89
0.22
-133.87%
100.42%
Similar stocks (13)
Artivion, Inc.
AORT
Orthofix Medical Inc.
OFIX
Surmodics, Inc.
SRDX
NeuroPace, Inc.
NPCE
CVRx, Inc.
CVRX
Electromed, Inc.
ELMD
Modular Medical, Inc.
MODD
enVVeno Medical Corporation
NVNO
Movano Inc.
MOVE
STRATA Skin Sciences, Inc.
SSKN
Nexalin Technology, Inc.
NXL
INVO Bioscience, Inc.
INVO
Bluejay Diagnostics, Inc.
BJDX
Similar stocks (13)
Artivion, Inc.
AORT
Orthofix Medical Inc.
OFIX
Surmodics, Inc.
SRDX
NeuroPace, Inc.
NPCE
CVRx, Inc.
CVRX
Electromed, Inc.
ELMD
Modular Medical, Inc.
MODD
enVVeno Medical Corporation
NVNO
Movano Inc.
MOVE
STRATA Skin Sciences, Inc.
SSKN
Nexalin Technology, Inc.
NXL
INVO Bioscience, Inc.
INVO
Bluejay Diagnostics, Inc.
BJDX